Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

New E-mail Newsletter for Providers in Limited-Resource Settings

March 2003

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

"HIV & AIDS Treatment in Practice" is a new e-mail newsletter for doctors, nurses, health care workers and community treatment advocates. It will be published twice every month by NAM, the UK-based HIV information charity behind www.aidsmap.com.

The goal of HATIP is to consider how appropriate and effective treatment, including but not limited to antiretroviral (ARV) drugs, can become a practical reality in settings with few resources. Each newsletter will contain specialist comment from doctors with expertise in delivering ARVS and AIDS treatment in resource-limited settings. Julian Meldrum, the editor, says HATIP recognizes that "for medicines to be effective in the real world, other things are important besides the supply of drugs, including the relationships between treatment providers and people with HIV as well as wider patterns of support and care within families and communities."

Each edition will review one major topic in HIV and AIDS treatment. The first issue features a review of the place of co-trimoxazole prophylaxis (CTX) in expanding treatment for people with HIV. It asks who could benefit from CTX prophylaxis and sets out some issues for individuals and communities in supporting CTX use. It looks at issues raised where CTX is promoted in the absence of access to ARV and finally at how it might be used to support the introduction of ARVs when these become available. The article includes commentary from Dr. Vijay Anthony Prabhu (India), Dr. Adama Ndir (Senegal), Dr. Leon Regensberg, Dr. Douglas Wilson (South Africa), Molly Tumusiime (Uganda) and Prof. Brian Gazzard (UK).

You can subscribe to the newsletter by visiting www.aidsmap.com or by sending an e-mail with your name, e-mail address and the country in which you work to: hatip@nam.org.uk with the words "add HATIP list" in the subject line.

Advertisement

Back to the GMHC Treatment Issues March 2003 contents page.

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Gay Men's Health Crisis. It is a part of the publication GMHC Treatment Issues. Visit GMHC's website to find out more about their activities, publications and services.
 
See Also
More HIV Treatment Resources

Tools
 

Advertisement